These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35714448)

  • 21. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis.
    Corrado L; Ratti A; Gellera C; Buratti E; Castellotti B; Carlomagno Y; Ticozzi N; Mazzini L; Testa L; Taroni F; Baralle FE; Silani V; D'Alfonso S
    Hum Mutat; 2009 Apr; 30(4):688-94. PubMed ID: 19224587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wide phenotypic spectrum of the TARDBP gene: homozygosity of A382T mutation in a patient presenting with amyotrophic lateral sclerosis, Parkinson's disease, and frontotemporal lobar degeneration, and in neurologically healthy subject.
    Mosca L; Lunetta C; Tarlarini C; Avemaria F; Maestri E; Melazzini M; Corbo M; Penco S
    Neurobiol Aging; 2012 Aug; 33(8):1846.e1-4. PubMed ID: 22398199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations.
    Kühnlein P; Sperfeld AD; Vanmassenhove B; Van Deerlin V; Lee VM; Trojanowski JQ; Kretzschmar HA; Ludolph AC; Neumann M
    Arch Neurol; 2008 Sep; 65(9):1185-9. PubMed ID: 18779421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
    Van Deerlin VM; Leverenz JB; Bekris LM; Bird TD; Yuan W; Elman LB; Clay D; Wood EM; Chen-Plotkin AS; Martinez-Lage M; Steinbart E; McCluskey L; Grossman M; Neumann M; Wu IL; Yang WS; Kalb R; Galasko DR; Montine TJ; Trojanowski JQ; Lee VM; Schellenberg GD; Yu CE
    Lancet Neurol; 2008 May; 7(5):409-16. PubMed ID: 18396105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant TDP-43 Causes Early-Stage Dose-Dependent Motor Neuron Degeneration in a TARDBP Knockin Mouse Model of ALS.
    Ebstein SY; Yagudayeva I; Shneider NA
    Cell Rep; 2019 Jan; 26(2):364-373.e4. PubMed ID: 30625319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred.
    Williams KL; Durnall JC; Thoeng AD; Warraich ST; Nicholson GA; Blair IP
    J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1286-8. PubMed ID: 19864664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis.
    Kirby J; Goodall EF; Smith W; Highley JR; Masanzu R; Hartley JA; Hibberd R; Hollinger HC; Wharton SB; Morrison KE; Ince PG; McDermott CJ; Shaw PJ
    Neurogenetics; 2010 May; 11(2):217-25. PubMed ID: 19760257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and characterization of a human iPSC line from an ALS patient carrying the Q66K-MATR3 mutation.
    Pollini D; Loffredo R; Cardano M; Conti L; Lattante S; Notarangelo A; Sabatelli M; Provenzani A
    Stem Cell Res; 2018 Dec; 33():146-150. PubMed ID: 30366341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in the cleavage site N291 of TDP-43 protein in a familial case of amyotrophic lateral sclerosis.
    Chami AA; Beltran S; Corcia P; Andres CR; Laumonnier F; Blasco H; Vourc'H P
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):463-466. PubMed ID: 32301341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability.
    Bilican B; Serio A; Barmada SJ; Nishimura AL; Sullivan GJ; Carrasco M; Phatnani HP; Puddifoot CA; Story D; Fletcher J; Park IH; Friedman BA; Daley GQ; Wyllie DJ; Hardingham GE; Wilmut I; Finkbeiner S; Maniatis T; Shaw CE; Chandran S
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5803-8. PubMed ID: 22451909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation in the RRM2 domain of TDP-43 in Amyotrophic Lateral Sclerosis with rapid progression associated with ubiquitin positive aggregates in cultured motor neurons.
    Maurel C; Madji-Hounoum B; Thepault RA; Marouillat S; Brulard C; Danel-Brunaud V; Camdessanche JP; Blasco H; Corcia P; Andres CR; Vourc'h P
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):149-151. PubMed ID: 28705014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43.
    Matsukawa K; Hashimoto T; Matsumoto T; Ihara R; Chihara T; Miura M; Wakabayashi T; Iwatsubo T
    J Biol Chem; 2016 Nov; 291(45):23464-23476. PubMed ID: 27634045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo.
    Williamson MG; Finelli MJ; Sleigh JN; Reddington A; Gordon D; Talbot K; Davies KE; Oliver PL
    Hum Mol Genet; 2019 Nov; 28(21):3584-3599. PubMed ID: 31642482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.
    Bury JJ; Highley JR; Cooper-Knock J; Goodall EF; Higginbottom A; McDermott CJ; Ince PG; Shaw PJ; Kirby J
    Neuropathology; 2016 Apr; 36(2):125-34. PubMed ID: 26303227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
    Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
    Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations.
    De Marco G; Lupino E; Calvo A; Moglia C; Buccinnà B; Grifoni S; Ramondetti C; Lomartire A; Rinaudo MT; Piccinini M; Giordana MT; Chiò A
    Acta Neuropathol; 2011 May; 121(5):611-22. PubMed ID: 21120508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases.
    Lenzi J; Pagani F; De Santis R; Limatola C; Bozzoni I; Di Angelantonio S; Rosa A
    Stem Cell Res; 2016 Jul; 17(1):140-7. PubMed ID: 27318155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allele-specific silencing as therapy for familial amyotrophic lateral sclerosis caused by the p.G376D
    Romano R; De Luca M; Del Fiore VS; Pecoraro M; Lattante S; Sabatelli M; La Bella V; Bucci C
    Brain Commun; 2022; 4(6):fcac315. PubMed ID: 36751500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.